rs7157465

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_182914.3(SYNE2):​c.7075A>G​(p.Ser2359Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00876 in 1,614,154 control chromosomes in the GnomAD database, including 752 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S2359N) has been classified as Benign.

Frequency

Genomes: 𝑓 0.037 ( 327 hom., cov: 33)
Exomes 𝑓: 0.0059 ( 425 hom. )

Consequence

SYNE2
NM_182914.3 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 2.68

Publications

5 publications found
Variant links:
Genes affected
SYNE2 (HGNC:17084): (spectrin repeat containing nuclear envelope protein 2) The protein encoded by this gene is a nuclear outer membrane protein that binds cytoplasmic F-actin. This binding tethers the nucleus to the cytoskeleton and aids in the maintenance of the structural integrity of the nucleus. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
SYNE2 Gene-Disease associations (from GenCC):
  • autosomal dominant Emery-Dreifuss muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Emery-Dreifuss muscular dystrophy 5, autosomal dominant
    Inheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • left ventricular noncompaction
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0016507208).
BP6
Variant 14-64031211-A-G is Benign according to our data. Variant chr14-64031211-A-G is described in ClinVar as Benign. ClinVar VariationId is 130507.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.12 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SYNE2NM_182914.3 linkc.7075A>G p.Ser2359Gly missense_variant Exon 45 of 116 ENST00000555002.6 NP_878918.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SYNE2ENST00000555002.6 linkc.7075A>G p.Ser2359Gly missense_variant Exon 45 of 116 1 NM_182914.3 ENSP00000450831.2

Frequencies

GnomAD3 genomes
AF:
0.0365
AC:
5557
AN:
152188
Hom.:
324
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.123
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0145
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0148
Gnomad SAS
AF:
0.0157
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.000397
Gnomad OTH
AF:
0.0263
GnomAD2 exomes
AF:
0.0116
AC:
2895
AN:
249390
AF XY:
0.00981
show subpopulations
Gnomad AFR exome
AF:
0.131
Gnomad AMR exome
AF:
0.00730
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00884
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000283
Gnomad OTH exome
AF:
0.00528
GnomAD4 exome
AF:
0.00586
AC:
8563
AN:
1461848
Hom.:
425
Cov.:
31
AF XY:
0.00561
AC XY:
4083
AN XY:
727224
show subpopulations
African (AFR)
AF:
0.136
AC:
4558
AN:
33476
American (AMR)
AF:
0.00751
AC:
336
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.0372
AC:
1475
AN:
39692
South Asian (SAS)
AF:
0.0139
AC:
1197
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.00624
AC:
36
AN:
5768
European-Non Finnish (NFE)
AF:
0.000285
AC:
317
AN:
1111990
Other (OTH)
AF:
0.0107
AC:
644
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
432
864
1297
1729
2161
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
182
364
546
728
910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0366
AC:
5579
AN:
152306
Hom.:
327
Cov.:
33
AF XY:
0.0354
AC XY:
2638
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.123
AC:
5113
AN:
41544
American (AMR)
AF:
0.0144
AC:
221
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.0148
AC:
77
AN:
5186
South Asian (SAS)
AF:
0.0155
AC:
75
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.000397
AC:
27
AN:
68032
Other (OTH)
AF:
0.0293
AC:
62
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
257
514
770
1027
1284
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
56
112
168
224
280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00845
Hom.:
104
Bravo
AF:
0.0414
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.120
AC:
446
ESP6500EA
AF:
0.000608
AC:
5
ExAC
AF:
0.0144
AC:
1736
Asia WGS
AF:
0.0320
AC:
110
AN:
3478
EpiCase
AF:
0.000273
EpiControl
AF:
0.000415

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Oct 29, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Emery-Dreifuss muscular dystrophy 5, autosomal dominant Benign:3
Apr 07, 2016
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

SYNE2-related disorder Benign:1
Jan 31, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
16
DANN
Benign
0.96
DEOGEN2
Benign
0.029
.;T;T;T
Eigen
Benign
-0.56
Eigen_PC
Benign
-0.47
FATHMM_MKL
Benign
0.47
N
LIST_S2
Benign
0.83
T;T;T;T
MetaRNN
Benign
0.0017
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
2.0
M;.;M;.
PhyloP100
2.7
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-1.6
N;.;N;N
REVEL
Benign
0.081
Sift
Benign
0.037
D;.;D;D
Sift4G
Uncertain
0.040
D;D;D;D
Polyphen
0.0040
B;.;B;.
Vest4
0.085
MPC
0.047
ClinPred
0.013
T
GERP RS
2.7
Varity_R
0.055
gMVP
0.11
Mutation Taster
=288/12
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7157465; hg19: chr14-64497929; COSMIC: COSV59952619; API